Clinical Trials Directory

Trials / Completed

CompletedNCT01030796

Quitting Caffeine for Better Glucose Metabolism

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This project is a pilot study of caffeine abstinence in coffee-drinkers who have type 2 diabetes. Evidence suggests that caffeine may impair the control of glucose levels, especially in those people who have type 2 diabetes. Eliminating caffeinated beverages from the diet might improve glucose control, but the difficulty of quitting is unknown. This pilot study will follow a small number of type 2 diabetic patients for three months after a brief intervention designed to help people quit caffeine. Data on success with maintaining abstinence and on changes in glucose control will be collected.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCaffeine abstinenceBrief instruction on beginning and maintaining caffeine abstinence.

Timeline

Start date
2009-12-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2009-12-11
Last updated
2011-02-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01030796. Inclusion in this directory is not an endorsement.

Quitting Caffeine for Better Glucose Metabolism (NCT01030796) · Clinical Trials Directory